Fresenius Medical Care AG & Co. KGaA (FME) Given a €82.00 Price Target by Jefferies Financial Group Analysts

Share on StockTwits

Jefferies Financial Group set a €82.00 ($95.35) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report issued on Tuesday. The brokerage currently has a neutral rating on the stock.

Several other research analysts have also commented on FME. Deutsche Bank set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, October 5th. Sanford C. Bernstein set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, July 20th. Commerzbank set a €82.00 ($95.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Friday, July 13th. Goldman Sachs Group set a €98.00 ($113.95) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Thursday, August 30th. Finally, Independent Research set a €80.00 ($93.02) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Wednesday, October 17th. Eight research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The stock has an average rating of Buy and a consensus price target of €92.13 ($107.13).

Shares of FME opened at €69.54 ($80.86) on Tuesday. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €75.53 ($87.83) and a twelve month high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Further Reading: What is a Leveraged Buyout (LBO)?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply